Sidlenafil in Combination With Oral Anticoagulants in Patients With Intermediate-high Risk of Pulmonary Embolism

Clinical trial NCT02946944 · UNKNOWN

Trial details

NCT number: NCT02946944
Sponsor: Meshalkin Research Institute of Pathology of Circulation
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Pulmonary Embolism Intermediate-high Risk Combination of Oral Anticoagulation Therapy and Sildenafil

Start date: 2016-10-01
Primary completion: 2020-10-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.